| Net Cash Provided by (Used in) Operating Activities |
$2,132,000,000 |
USD |
16% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$802,000,000 |
USD |
-256% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,006,000,000 |
USD |
740% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
573,042,256 |
shares |
0.25% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$12,835,000,000 |
USD |
-11% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,000,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$2,808,000,000 |
USD |
-4.3% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$64,000,000 |
USD |
-9.9% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$5,029,000,000 |
USD |
98% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$2,546,000,000 |
USD |
-18% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$68,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
10,700 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$15,000,000 |
USD |
-17% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$4,678,000,000 |
USD |
2.2% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
10,700 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,807,000,000 |
USD |
-4.3% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$5,596,000,000 |
USD |
66% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |